Horizon Discovery (Montserrat) S.A.
GPTKB entity
Statements (54)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:hasAwards |
Excellence in Research Award 2021
Innovative Technology Award 2019 Best_Biotechnology_Company_2020 |
gptkbp:hasClient |
Academic institutions
Pharmaceutical companies Biotech_companies |
gptkbp:hasEmployees |
100-200
|
gptkbp:hasEvents |
Annual Biotechnology Conference
Investor Relations Meeting Gene Editing Symposium |
gptkbp:hasFunding |
Venture capital
|
gptkbp:hasGoals |
Biotechnology
|
gptkbp:hasHistoricalSignificance |
gptkb:Cambridge,_UK
|
gptkbp:hasLocation |
gptkb:Montserrat
|
gptkbp:hasPartnershipsWith |
Various academic institutions
|
gptkbp:hasProductLine |
CRISPR technology
Cell line development Custom gene editing Gene modulation services |
gptkbp:hasPublications |
Research papers
Scientific journals Case studies |
gptkbp:hasResearchFocus |
Genetic research
|
gptkbp:hasService |
Training services
Consulting services Technical support services Transgenic models Cell-based assays Drug discovery services Quality control services Preclinical services Antibody production services Protein expression services CRISPR screening services Cell line engineering services Clinical trial support services Gene delivery services Gene knock-in services Gene knockout services Regulatory support services Biomarker_discovery_services |
gptkbp:hasSubsidiary |
gptkb:Horizon_Discovery_Inc.
|
gptkbp:hasTechnology |
CRISPR-Cas9
TALENs Zinc finger nucleases Gene_editing_technology |
gptkbp:hasWebsite |
www.horizondiscovery.com
|
https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery (Montserrat) S.A.
|
gptkbp:isFocusedOn |
gptkb:London_Stock_Exchange
|
gptkbp:isPartOf |
gptkb:Horizon_Discovery_Group_plc
|
gptkbp:keyPeople |
gptkb:Dr._Darrin_Disley
|
gptkbp:providesServices |
Gene_editing
|
gptkbp:wasFoundedIn |
2012
|